Grant · National Institutes of Health
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
At a glance
- Where
- United States
- Closes
- Posted
Who can apply isn't stated. Before you apply, check the organisation's page for nationality or work-permit rules.
Opens on their website. We are not involved in the application.
About this opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.
Who may apply
- No country restriction stated
Know someone this suits?
Sharing is how most people here hear about an opportunity in time.
Where this came from
We found this listing at the link below. Always confirm the details with the organisation before applying.
View the original postingWe never charge for access to an opportunity. If one asks you to pay, report it.